1. Home
  2. HRMY vs ESRT Comparison

HRMY vs ESRT Comparison

Compare HRMY & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$39.92

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Empire State Realty Trust Inc.

ESRT

Empire State Realty Trust Inc.

HOLD

Current Price

$4.06

Market Cap

834.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
ESRT
Founded
2017
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
834.5M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
HRMY
ESRT
Price
$39.92
$4.06
Analyst Decision
Buy
Hold
Analyst Count
9
3
Target Price
★ $44.11
$6.35
AVG Volume (30 Days)
861.2K
★ 3.9M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
★ 2.49%
EPS Growth
★ 7.97
N/A
EPS
★ 1.84
N/A
Revenue
★ $868,453,000.00
$768,270,000.00
Revenue This Year
$19.75
$4.26
Revenue Next Year
$12.88
$1.52
P/E Ratio
$21.74
★ N/A
Revenue Growth
★ 21.51
0.05
52 Week Low
$25.52
$3.93
52 Week High
$43.49
$8.04

Technical Indicators

Market Signals
Indicator
HRMY
ESRT
Relative Strength Index (RSI) 45.44 36.02
Support Level $37.30 $3.93
Resistance Level $43.38 $5.85
Average True Range (ATR) 1.21 0.13
MACD -0.38 0.02
Stochastic Oscillator 12.45 33.33

Price Performance

Historical Comparison
HRMY
ESRT

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About ESRT Empire State Realty Trust Inc.

Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.

Share on Social Networks: